Back

Sex differences in guideline-based pharmacological treatment after acute coronary syndrome with reduced ejection fraction

10 May 2026 (13:30 - 14:00)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes: predictors and outcomes Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Isabel Nobrega Fernandes

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)

4 More presentations in this session

Presentation thumbnail
Predictors of heart failure in non-ST segment elevation acute coronary syndrome
Doctor L. Sousa Azevedo (Vila Real, PT)
Abstract Slides
Presentation thumbnail
Sex-related determinants and outcomes of reverse left ventricular remodeling in STEMI patients with reduced LVEF after primary PCI
Assistant Professor D. Arnautu (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Early coronary angiography and survival in older adults with nstemi: a frailty-adjusted analysis
Mrs X. Zalazar (Atlanta, US)
Abstract Slides
Presentation thumbnail
Patients admitted with new-onset heart failure after acute coronary syndrome. Do they require further invasive ischemic evaluation?
Doctor M. Ferreira (Funchal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute coronary syndromes: predictors and outcomes

The Event

Event poster

Heart Failure 2026

10 May 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Sex differences in adherence to guideline-directed medical therapy and their prognostic impact in HFrEF: insights from the KorAHF III registry
thumbnail
Congress Presentation
Are we gender-biased in prescription practices?
thumbnail
Congress Presentation
Use of guideline-directed medical therapy in women hospitalised for decompensated heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources